Author

Fulai Zhou

Chinese Academy of SciencesORCID 0000-0002-3840-6757Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Organism:virus· 1

Frequent Co-Authors

H. Eric XuiD· 3 shared Hualiang JiangiD· 3 shared Chunyou MaoiD· 2 shared Minqi GaoiD· 2 shared Shuyang ZhangiD· 2 shared Wanchao YiniD· 2 shared Xiaodong LuaniD· 2 shared Yan ZhangiD· 2 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMolecular Biology

H. Eric XuORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Molecular BiologyProceedings of the National Academy of SciencesPeer-reviewedOct 1, 2021

Constitutive signal bias mediated by the human GHRHR splice variant 1

Zhaotong Cong, Fulai Zhou, Chao Zhang…·Ming‐Wei Wang

The paper identifies a splice variant of the GHRHR receptor that mediates constitutive signal bias towards β-arrestin recruitment, impacting downstream signaling pathways in prostate cancer cells.

37 citations

humanproteomics

𝕏 PostBluesky

Molecular BiologybioRxivPreprintOct 6, 2020

Structural basis for repurposing a 100-years-old drug suramin for treating COVID-19

Wanchao Yin, Xiaodong Luan, Zhihai Li…·H. Eric Xu

The paper discovers suramin as a potent inhibitor of SARS-CoV-2 RNA polymerase and provides its structural mechanism for repurposing in treating COVID-19.

5 citations

experimental assaydrug response / drug discovery

𝕏 PostBluesky

Molecular BiologySciencePeer-reviewedMay 1, 2020

Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir

Wanchao Yin, Chunyou Mao, Xiaodong Luan…·H. Eric Xu

This study reports the structure of SARS-CoV-2 RdRp with and without Remdesivir, showing how the drug inhibits viral RNA replication by terminating chain elongation.

1,219 citationstop 1%

virusexperimental assay

𝕏 PostBluesky